CureVac (CVAC) Operating Income (2019 - 2025)
Historic Operating Income for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $362.7 million.
- CureVac's Operating Income fell 1035.93% to $362.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.4 million, marking a year-over-year increase of 2480.14%. This contributed to the annual value of $189.9 million for FY2024, which is 16435.62% up from last year.
- According to the latest figures from Q3 2025, CureVac's Operating Income is $362.7 million, which was down 1035.93% from -$69.9 million recorded in Q2 2025.
- CureVac's 5-year Operating Income high stood at $404.6 million for Q3 2024, and its period low was -$178.0 million during Q2 2021.
- For the 5-year period, CureVac's Operating Income averaged around -$32.3 million, with its median value being -$64.8 million (2023).
- As far as peak fluctuations go, CureVac's Operating Income plummeted by 187017.13% in 2022, and later skyrocketed by 78775.91% in 2024.
- Over the past 5 years, CureVac's Operating Income (Quarter) stood at -$6.3 million in 2021, then tumbled by 1870.17% to -$124.0 million in 2022, then grew by 23.62% to -$94.7 million in 2023, then skyrocketed by 50.57% to -$46.8 million in 2024, then skyrocketed by 874.82% to $362.7 million in 2025.
- Its Operating Income stands at $362.7 million for Q3 2025, versus -$69.9 million for Q2 2025 and -$57.6 million for Q1 2025.